The first involves constitutive oncogenic signaling, such as via activation of the AKT pathway or gene amplification upregulated PD-L1 expression on tumor cells, independently of the inflammatory signal in the tumor ME, and referred to as innate immune resistance [16]. Here, CD274 is linked to neoplasm.